Product Overview
AOD9604 is a modified fragment of human growth hormone (hGH) supplied by PeptaCo for qualified laboratory research. It corresponds to the C-terminal fragment (amino acids 176-191) of hGH with a tyrosine addition at position 177. AOD9604 is widely referenced in metabolic research and fat metabolism investigations.
Key Product Details
- Product Name: AOD9604
- Specification: As listed per catalog variant
- Product Form: Lyophilized powder
- Category: Metabolic Research Peptides — hGH Fragment
- Peptide Sequence: H-Tyr-Met-Asp-Phe-Pro-Arg-His-Gln-Tyr-Arg-Arg-Glu-Thr-Gln-Lys-Leu-OH (modified)
Chemical Identity
AOD9604 is a 17-amino-acid peptide fragment derived from human growth hormone (amino acids 176-191 with modifications). Molecular Formula: C₇₈H₁₂₃N₂₃O₂₄S₂. Molecular Weight: ~1815 Da. The modification at position 177 enhances stability for research applications. This listing covers AOD9604 in multiple specifications (5mg, 10mg).
Research Context
AOD9604 is extensively studied in metabolic research for its effects on fat metabolism and lipid oxidation pathways. It is commonly referenced in investigations of energy metabolism, body composition, and peptide-mediated metabolic regulation. PeptaCo supplies AOD9604 in multiple specifications to support diverse research requirements.
Storage and Handling
Store in a cool, dry place away from direct light. Follow batch-specific storage instructions provided with the certificate of analysis. Avoid repeated freeze-thaw cycles. Handle using standard laboratory practices.
Documentation and Quality
Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package, which may include identity confirmation, purity analysis, and batch traceability records.
Important Notice
This product is supplied for qualified laboratory research and analytical applications only. It is not for human or veterinary use. Product specifications may vary by batch. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.
